Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Buske

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Pathobiology of acute myeloid leukemia]Oliver Christ, Michaela Feuring-Buske, Wolfgang Hiddemann, et al.
Scientific Reports|January 19, 2018
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticlesTamoghna Mandal, Michaela Beck, Nicole Kirsten, et al.
Experimental Hematology|October 28, 2010
Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literatureNathalie Schöler, Christian Langer, Hartmut Döhner, et al.
Leukemia|November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitorsChristian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
Experimental Hematology|December 21, 2010
TET genes: new players in DNA demethylation and important determinants for stemnessFabian Mohr, Konstanze Döhner, Christian Buske, et al.
Haematologica|January 26, 2006
Current status and perspective of antibody therapy in follicular lymphomaChristian Buske, Oliver Weigert, Martin Dreyling, et al.
Current Oncology Reports|August 12, 2006
Investigational strategies in autologous stem cell transplantation for follicular lymphomaOliver Weigert, Martin Dreyling, Michael Unterhalt, et al.
Future Oncology (London, England)|May 10, 2017
An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirementsChristian Buske, Michinori Ogura, Hyuk-Chan Kwon, et al.
Leukemia|December 4, 2020
CXCR4 in Waldenström's Macroglobulinema: chances and challengesLisa Marie Kaiser, Zachary R Hunter, Steven P Treon, et al.
Haematologica|November 4, 2005
Effects of the protein tyrosine kinase inhibitor, SU5614, on leukemic and normal stem cellsNatalia Arseni, Farid Ahmed, Wolfgang Hiddemann, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Medizinische Klinik (Munich, Germany : 1983)|April 12, 2007
[Pathobiology of acute myeloid leukemia]Oliver Christ, Michaela Feuring-Buske, Wolfgang Hiddemann, et al.
Scientific Reports|January 19, 2018
Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticlesTamoghna Mandal, Michaela Beck, Nicole Kirsten, et al.
Experimental Hematology|October 28, 2010
Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literatureNathalie Schöler, Christian Langer, Hartmut Döhner, et al.
Leukemia|November 19, 2022
Managing Waldenström's macroglobulinemia with BTK inhibitorsChristian Buske, Wojciech Jurczak, Joe-Elie Salem, et al.
Experimental Hematology|December 21, 2010
TET genes: new players in DNA demethylation and important determinants for stemnessFabian Mohr, Konstanze Döhner, Christian Buske, et al.
Haematologica|January 26, 2006
Current status and perspective of antibody therapy in follicular lymphomaChristian Buske, Oliver Weigert, Martin Dreyling, et al.
Current Oncology Reports|August 12, 2006
Investigational strategies in autologous stem cell transplantation for follicular lymphomaOliver Weigert, Martin Dreyling, Michael Unterhalt, et al.
Future Oncology (London, England)|May 10, 2017
An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirementsChristian Buske, Michinori Ogura, Hyuk-Chan Kwon, et al.
Leukemia|December 4, 2020
CXCR4 in Waldenström's Macroglobulinema: chances and challengesLisa Marie Kaiser, Zachary R Hunter, Steven P Treon, et al.
Haematologica|November 4, 2005
Effects of the protein tyrosine kinase inhibitor, SU5614, on leukemic and normal stem cellsNatalia Arseni, Farid Ahmed, Wolfgang Hiddemann, et al.
Pageof 15